To report clinical results in patients with testicular seminoma treated with postoperative radiotherapy with regard to survival, acute and late toxicity, and risk of second malignancy.
Materials and methods
176 stage I-II testicular seminoma patients treated with radiotherapy from 1964 to 1994 at the Radiotherapy Division of Pisa University, using 60Co or Linac, were analyzed retrospectively. The follow-up ranged from 0.13 to 32.37 years, with a median of 12.1 years. The observed numbers of second malignancies were compared with those expected, taking into account age, sex, and incidence rates from the Tuscany Tumor Registry.
Results
Overall and specific survival at 10-15 years were 89-82% and 93-92%, respectively. Multivariate analysis revealed a significantly better survival in patients younger than 50 years and in those treated with Linac. Severe late sequelae occurred in 8% of the patients. Sixteen second malignancies were observed (14 solid tumors and 2 leukemias); median latency was 13 years (range, 3-27) and the observed/expected ratio 1.4 (P not significant). Solid cancers were localized in the bladder (2), kidney (2), skin (2), stomach (1), prostate (1), lung (1), larynx (1), uvea (1) and contralateral testicle (1); 1 patient presented an intestinal carcinoid and 1 a metastasis from an unknown primary. The risk of a second malignancy was higher in the patient group receiving less than 4000 cGy (observed/expected, 2.8; P = 0.015).
Conclusions
The study confirmed the high cure rate in stage III seminomas after postoperative radiotherapy. Incidence of a second malignancy was higher than expected, but the difference was not statistically significant.
DosoretzD.E., ShipleyW.U., BlitzerP.D., GilbertS., PratJ., ParkhurstE.: Megavoltage irradiation of pure testicular seminoma: results and patterns of failure.Cancer, 48: 2184–2190, 1981.
2.
ZagarsG.K., BabainR.J.: Stage I testicular seminoma: rationale for postorchidectomy radiation therapy.Int J Radiat Oncol Biol Phys, 13: 155–162, 1987.
3.
LesterS.G., MorphisJ.G., HornbackN.B.: Testicular seminoma: analysis of treatment results and failures.Int J Radiat Oncol Biol Phys, 12: 353–358, 1986.
4.
HanksG.E., HerringD.F., KramerS.: Patterns of care outcome studies: results of the national practice in seminoma of the testis.Int J Radiat Oncol Biol Phys, 7: 1413–1417, 1981.
5.
ThomasG.M., RiderW.D., DemboA.J.: Seminoma of the testis: results of treatment and patterns of failure after radiation therapy.Int J Radiat Oncol Biol Phys, 8: 165–174, 1982.
6.
SauceW.T.: Testicular seminoma: analysis of radiation therapy for stage II disease.J Urol, 130: 702–703, 1983.
7.
LaiP.P., BernsteinM.J., KimH.: Radiation therapy for stage I and IIA testicular seminoma.Int J Radiat Oncol Biol Phys, 28: 373–379, 1994.
8.
ThomasG.: Over 20 years progress in radiation oncology: seminoma.Semin Radiat Oncol, 7: 135–145, 1997.
9.
SpeerT.D., SombeckM.D., ParsonJ.T.: Testicular seminoma: a failure analysis and literature review.Int J Radiat Oncol Biol Phys, 33: 89–97, 1995.
10.
AnscherM.S., MarksL.B., ShipleyW.U.: The role of radiotherapy in patients with advanced seminomatous germ cell tumors.Oncology, 6: 97–110, 1992.
11.
WardeP.R., GospodarowiczM.K., PanzarellaT.: Stage I testicular seminoma: results of adjuvant irradiation and surveillance.J Clin Oncol, 13: 2255–2262, 1995.
12.
Von der MaaseH., SpechtL., JacobsenG.K.: Surveillance following orchidectomy for stage I seminoma of the testis.Eur J Cancer, 14: 1931–1934, 1993.
13.
ShardaN.N., KinsellaT.J., RitterM.A.: Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early stage testicular seminoma.J Clin Oncol, 14: 2933–2939, 1996.
14.
MaierJ.G., SulakM.H., MittemeyerB.T.: Seminoma of the testis: analysis of treatment success and failure.Am J Roentgenol, 102: 596–602, 1968.
15.
WilliamsS.D., RothB.J.: Chemotherapy of testis cancer: a review.Int J Radiat Oncol Biol Phys, 22: 213–217, 1991.
16.
HallE.J.: Radiobiology for the radiologist4th edn, JB Lippincott, Philadelphia, 1994.
17.
BithellJ.F., StewartA.M.: Pre-natal irradiation and childhood malignancies: a review of British data from the Oxford survey.Br J Cancer, 31: 271–287, 1975.
18.
ColtmanC.A., DixonD.: Second malignancies complicating Hodgkin's disease. A Southwest Oncology Group 10-year follow-up.Cancer Treat Rep, 66: 1022–1033, 1982.
19.
DarbyS.C., DollR., GillS.K., SmithP.G.: Long-term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis.Br J Cancer, 55: 176–179, 1987.
20.
KratzikC., AigingerP., KuberW.: Risk factors for bilateral testicular germ cell tumors.Does heredity play a role? Cancer, 68: 916–921, 1991.
21.
HusseyD.H.: The testicle. In: Moss’ radiation oncology: rationale, technique, results,CoxJ.D. (Ed), 7th edn, pp 559–586, Mosby, St. Louis, 1994.
22.
BuiattiE., BalziD., BarchielliA., CarliS., CrocettiE., Giovan-nettiL.: Registro tumori toscano. In: Cancer incidence in five continents, vol VII, ParkinD.M., WhelanS.L., FerlayJ., RaymondL., YoungJ. (Eds), IARC Scientific Publications no. 143, pp 526–529, Lyon, 1997.
23.
KaplanE.L., MaierP.: Non parametric estimation from incomplete observations.J Am Stat Assoc, 53: 457–481, 1958.
24.
CoxD.R.: Regression models and life-table.J R Stat Soc [B], 34: 187–220, 1972.
25.
VallisK.A., HowardG.C., DuncanW.: Radiotherapy for stages III testicular seminoma: results and morbidity in 238 patients.Br J Radiol, 68: 400–405, 1995.
26.
CoiaL.R., HanksG.E.: Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma.Int J Radiat Oncol Biol Phys, 15: 29–35, 1988.
27.
SchlappackO.K., KratzikC., SchmidtW.: Response of the seminiferous epithelium to scattered radiation in seminoma patients.Cancer, 62: 1487–1491, 1988.
28.
FossaS.D., HorwichA., RussellJ.M.: Optimal planning target volume for stage I testicular seminoma: a Medical Research Council Randomized Trial.J Clin Oncol, 17: 1146–1154, 1999.
29.
WardeP.R., GospodarowiczM.K., GoodmanP.J.: Results of policy of surveillance in stage I seminoma.Int J Radiat Oncol Biol Phys, 27: 11–15, 1993.
30.
GospodarowiczM.K., SturgeonJ., JewettM.A.S.: Early stage and advanced seminoma: role of radiation therapy, surgery, and chemotherapy.Semin Oncol, 25: 160–173, 1998.
31.
GiacchettiS., RaoulY., WibaultP.: Treatment of stage I testis seminoma by radiotherapy: long-term results. A 30-year experience.Int J Radiat Oncol Biol Phys, 27: 3–9, 1993.
32.
HanksG.E., PetersT., OwenJ.: Seminoma of the testis: long-term beneficial and deleterious results of radiation. testis seminoma by radiotherapy: long-term results a 30-year experience.Int J Radiat Oncol Biol Phys, 24: 913–919, 1992.
33.
LedermanG.S., SheldonT.A., ChaffeyJ.T.: Cardiac disease after mediastinal irradiation for seminoma.Cancer, 60: 772–776, 1987.
34.
DosmanM.A., ZagarsG.K.: Post-orchiesctomy radiotherapy for stage I and II testicular seminoma.Int J Radiat Oncol Biol Phys, 26: 381–390, 1993.
35.
RonE., ModaneB.: Benign and malignant thyroid neoplasms after childhood irradiation from tinea capitis.J Natl Cancer Inst, 66: 7–11, 1980.
36.
RonE., ModaneB., BoiceJDJr.: Mortality from cancer and other causes following radiotherapy for ringworm of the scalp.Am J Epidemiol, 127: 713–725, 1988.
37.
BoiceJ.D., Engholm KleinermanR.A.: Radiation dose and second cancer risk in patients treated for cancer of the cervix.Radiat Res, 116: 355, 1988.
38.
BoiceJ.D., DayN.E., AndersenA.: Second cancers following radiation treatment for cervical cancers: an international collaboration among cancers registries.J Natl Cancer Inst, 74: 955–975, 1985.
39.
SwerdlowA., DouglasA., HudsonG., HudsonB., BennettM., McLennanK.: Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2486 patients in a British National Lymphoma Investigation.Br J Med, 304: 1137–1148, 1992.
40.
MollerH., MellemgaardA., JacobsenG.K., PedersenD., StormH.H.: Incidence of second primary cancer following testicular cancer.Eur J Cancer, 29: 672–676, 1993.
